ea0041gp97 | Diabetes (2) | ECE2016
Marco Martinez Amparo
, Martinez Garcia Ana
, Herranz Antolin Sandra
, Lopez Gallardo Gemma
, Jose Pines Corrales Pedro
, Quilez Toboso Rosa
, Aguirre Sanchez-Covisa Miguel
, Joaquin Alfaro Jose
The improvement of glycemic control and body weight reduction by GLP-1 receptor agonist (GLP1RA) has been demostred in randomized clinical trials, but comparative studies of the efficacy of different GLP1RA in real world and clinical practice setting are limited.Objectives: To compare the efficacy of liraglutide (LIRA), exenatide once weekly (EQW), and lisixenatide (LIXI) treatment in a real-world and clinical practice setting.Meth...